beatandraise : SEC Filings Research with AI

2.0.0.10 false Taxes on Income 000240 - Disclosure - Taxes on Income true false false false 1 usd $ false false Shares Standard http://www.xbrl.org/2003/instance shares xbrli 0 USD Standard http://www.xbrl.org/2003/iso4217 USD iso4217 0 USDperShare Divide http://www.xbrl.org/2003/iso4217 USD iso4217 http://www.xbrl.org/2003/instance shares xbrli 0 2 Taxes on Income [Abstract] 0 pfe_TaxesOnIncomeAbstract pfe false na duration string No definition available. false false false false false true false false false false false false 1 false false false false 0 0 false false false No definition available. false 3 Taxes on Income [Text Block] 1 us-gaap_IncomeTaxDisclosureTextBlock us-gaap true na duration string No definition available. false false false false false false false false false false false false 1 false false false false 0 0 <div class="BWxbrlnote12"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> <div> <div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"><a style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline" id="xbrlnote12" name="xbrlnote12">Note 12. Taxes on Income</a></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br/> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left">Our effective tax rate for continuing operations was 36.0% for the first quarter of 2010, compared to 28.2% for the first quarter of 2009. The higher tax rate for the first quarter of 2010 is primarily the result of:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br/> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" width="100%" cellpadding="0"> <tr valign="top"> <td align="right" style="WIDTH: 9pt" width="1%"> <div style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: symbol, serif">·  </div></td> <td width="99%"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: justify">higher amortization charges, primarily related to intangible assets acquired in connection with the acquisition of Wyeth, and the mix of jurisdictions in which those charges were incurred;</div></td></tr></table></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br/> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" width="100%" cellpadding="0"> <tr valign="top"> <td align="right" style="WIDTH: 9pt" width="1%"> <div style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: symbol, serif">·  </div></td> <td style="TEXT-ALIGN: left" width="99%"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt">the write-off of the deferred tax asset of approximately $270 million related to the Medicare Part D subsidy for retiree prescription drug coverage, resulting from changes in the U.S. healthcare legislation enacted in March 2010 concerning the tax treatment of that subsidy effective for tax years beginning after December 31, 2012;</div></td></tr></table></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br/> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" width="100%" cellpadding="0"> <tr valign="top"> <td align="right" style="WIDTH: 9pt" width="1%"> <div style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: symbol, serif">·  </div></td> <td width="99%"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: justify">the expiration of the U.S. research tax credit; and</div></td></tr></table></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br/> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" width="100%" cellpadding="0"> <tr valign="top"> <td align="right" style="WIDTH: 9pt" width="1%"> <div style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: symbol, serif">·  </div></td> <td width="99%"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: justify">the increase in non-deductible in-process research and development charges.</div></td></tr></table></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br/> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt">These factors were partially offset by $410 million in tax benefits for the resolution of certain tax positions pertaining to prior years with various foreign tax authorities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br/> </div></div></div></div></div> Note 12. Taxes on Income Our effective tax rate for continuing operations was 36.0% for the first quarter of 2010, compared to 28.2% for the first quarter of false false false Description containing the entire income tax disclosure. Examples include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables. Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 136, 172 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 43, 44, 45, 46, 47, 48, 49 false false 1 2 false UnKnown UnKnown UnKnown false true